Lotus Pharmaceuticals, Inc.

LTUSOTCFinancial Services● Active

$0.00

+$0.00(+0.00%)

Market Cap$98773

P/E Ratio—

52W High$0.0111

52W Low$0.0025

Avg Volume2K

Open$0.00

Beta-1.64

Earnings Financials Revenue

Lotus Pharmaceuticals, Inc. (LTUS) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LTUS · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2026	May 15, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Mar 12, 2026	—	—	—	—	—	—
◌ Q4 FY2025	Nov 12, 2025	—	—	—	—	—	—
◌ Q3 FY2025	Aug 6, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 27, 2025	—	—	—	—	—	—

Q2 FY2026

May 15, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 12, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2025

Nov 12, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 6, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 27, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for LTUS.

About Earnings & Data Methodology

Lotus Pharmaceuticals, Inc. (LTUS) reports earnings quarterly as a OTC-listed Shell Companies company. The next LTUS earnings date is expected around September 1, 2026.

Each quarter, investors track LTUS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LTUS revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LTUS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LTUS earnings · 3 questions

Lotus Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. LTUS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LTUS historically reports after market close (AMC).

LTUS earnings datewhen is LTUS earningsLTUS next earnings datewhen does LTUS report earningsLTUS earnings calendar

▸ Source: FMP · Lotus Pharmaceuticals, Inc. SEC filings · US GAAP · Lotus Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026